Other major drug makers are thought to also be working on renin inhibitors.
But, he wrote, "a larger, population-based study will be important in confirming the results of this paper."
"It's a new window into heart disease."
"We think everybody should have this simple and accurate test," he said in the interview.
"But the real dynamite is in the patients who didn't have any of the usual risk factors," Dr. Laragh said in an interview.
Regardless of how the statisticians broke down the patients into various groups, those with high renin profiles almost invariably had the highest incidence of heart attacks.
